Uncategorized

With the Brexit transition period drawing to an end on 31st December 2020, we shall enter the new year with many rules changing on the import of goods from the EU into the UK. We have been working tirelessly to adapt to this new environment and ever striving to bridge this gap between Europe and the UK.

We are very proud to announce the launch of a new Eumedica entity: Eumedica Pharma Ltd. This new entity will enable us to overcome many of the challenges Brexit has presented all companies who rely on a European partnership, like us.

The transition period

Back in January 2020 saw the beginning of the transition period to the end of this year. We formed a new alliance with a UK distributor to store and ship medicines throughout the UK hospital network to maintain our commitment to vital medical care continuity. This guaranteed no disruption to the supply of our medicines for our customers and patients throughout this uncertain and trying period.

Our customers and the new entity

Our main priority is to limit the impact on our customers as much as possible. From the 1st January 2021 the only aspect that will change is our contact details; the team who have always managed your orders and the distributors who have delivered our medicines to you, will remain the same. Furthermore, our sales and promotion team, led by Véronique Van Ranst, Head of the UK Markets, continue to support you and will be on hand to deal with any queries you may have.

New contact details

From 1st January 2021 please use the following contact details if you contact us from the UK:

Eumedica Pharma Ltd
8 Northumberland Avenue, WC2N 5BY, London, United Kingdom
Phone +44 (0) 20 8444 3377 | Fax +44 (0) 20 8444 6866
Email : e-orders@eumedica.co.uk | Website : http://www.eumedica.co.uk
VAT : GB350 1686 15

The creation of Eumedica Pharma Ltd. is another step forward to allow us to continue providing a first-class service to our customers and ensuring medical care continuity in the UK.

For more information, please contact us now.

In the current climate of the Coronavirus pandemic, Eumedica is dedicated to carry out its mission: “Ensuring Medical Care Continuity”. This is only possible through the continued hard-work and dedication of our colleagues. This is why the health and safety of our colleagues is of the utmost importance, now more than ever. Where feasible, we have implemented homeworking. Some of what we do needs to be done on site; we therefore constantly monitor the situation and are taking appropriate measures to ensure the safety of our people.

What Eumedica is doing in-house

Providing a safe working environment for all of our colleagues is our top-priority. To achieve this, we have reduced the number of people on site to the absolute minimum required and have implemented home-based working for all other colleagues. We are raising awareness internally around increased hygiene measures, strengthening our disinfection plan, cancelling all non-essential business travel, and keeping a minimum of 1.5m distance. With regards to our clients, we maintain contact using video-conferencing, telephone and email. We are always available to answer our clients queries!

In a matter of just a few days, we have all embraced the new digital tools to keep our teams working for you!

Medicines distribution, a vital service

As a key distributor of medicines, we are a vital service for the population across many countries. Consequently, it is crucial to continue our work so patients can receive their treatment on time. All our teams work tirelessly to maintain the supply of medicines for these patients. Therefore, we guarantee to remain operational and continue all our GDP and GMP activities and to manage all orders and requests. Meanwhile, we will be dynamic to any changes made by the authorities on a local, continental or worldwide scale, and act accordingly.

In these challenging times, we would like to thank all of our colleagues who are working hard to deliver vital medicines to patients. While we make sure the conditions are as safe as possible, we are proud to see such flexibility and cohesion to fulfil our mission: “Ensuring Medical Care Continuity”!

For over two years, Eumedica has been a certified and licensed PAXXO partner for distributing the Pactosafe 4.0 system in Belgium, Luxembourg and northern France (Ardennes, Meurthe-et-Moselle, Meuse and Nord).

This equipment is crucial to health care staff as it provides a safer working environment, preventing the exposure and consequences related to cytotoxic drug contamination and inhalation. At the same time, it allows health care staff to carry out their duties in a hygienic working environment.

Pactosafe 4.0 was developed by the world leaders in the field of waste management to prevent health care personnel from the exposure of hazardous drugs as well as infection control and to avoid odour. It has been developed to quickly store and tightly pack contaminated waste without any extra handling and therefore preventing contamination. Pactosafe is 100% airtight and the bag cassette is permeation tested for cytotoxic drugs which prevents health care staff from hazardous exposure.

Used worldwide within health care facilities, the new Pactosafe 4.0 offers easier use and maintenance. Furthermore, it is also more eco-friendly as it uses 40% less materials.

For more information about this unique equipment, or to arrange a free demo at your premises, please feel free to contact us.

Download the brochure here:

FR – NL

Remember back in February the Falsified Medicines Directive (FMD) came into force in the European Union. Eumedica is thrilled to announce that a new serialization printing line has been setup to enlarge the  service range we propose to  the pharmaceutical industry.

What does the FMD imply?

Back to basics first. This directive imposes amongst others a unique serial number printed on the box on all products prescribed in the European zone.

he goal: limit to the maximum the access to counterfeit products on the market as this represents a major risk for the patients’ health.

On every packaging, a data matrix and other required data must be printed:

• The product code (code GTIN)
• The unique and random serial number
• The lot number
• The expiration date

What we offer

To help you face this new challenge in our industry, we have invested in a new printing line specifically set up to comply with FMD requirements. Thanks to this equipment  our team of experts can now provide you with a flexible solution to meet your needs and expectations.

In addition, we can also:

• manage the status check of the serial numbers
• decommission and/or recommission unique serial numbers

Are you looking for a new partner for printing your packaging? Do you need further information? Feel free to contact us right now!

We are pleased to announce that Eumedica will be exhibiting during the upcoming “CPhI Worldwide”, the world’s largest pharmaceutical exhibition.

This event is a perfect opportunity to meet our partners as well as new key pharma industry professionals from more than 150 countries.

To this occasion we will of course present our different services:

• Distribution and Activation
• Tailored Logistics and Clinical Supplies
• On-Demand Packaging
• Regulatory & Pharmacovigilance

The congress will take place from the 5th to the 7th of November in Frankfurt, Germany, at the Messe Frankfurt GmbH.

Tick the date in your agenda and come visit us on our stand 121F51 in Hall 12.1.

We look forward to seeing you there.

The Eumedica Team.

Back in April we participated as exhibitor to the 29^th ECCMID (European Congress of Clinical Microbiology & Infectious Diseases) in Amsterdam, Netherlands.

We would like to thank everyone who came and visited us during the congress. It was a pleasure to meet you and discuss the latest developments in infectious diseases, infection control and clinical microbiology.

We hope that you enjoyed the congress and received all the answers you were looking for.

A few months have passed now and you still have remaining questions? You couldn’t come to the ECCMID? In any case, do not hesitate to contact us.

We look forward to seeing you again soon,

The Eumedica Team.

The final decision on Brexit has still to be made.  The new extension to Article 50, negotiated between Theresa May and the European leaders, means that the deferment of Brexit could continue to 31^st October 2019. Whilst Theresa May agreed this date, she still hopes to convince the UK parliament to approve the Withdrawal Agreement and on or before May 22^nd.

Our customers’ specific needs are our top priority. The Eumedica team has worked hard to make any Brexit outcome as smooth as possible, with no disruption to the supply of our medicines to UK hospitals.

Eumedica delivers medicines to hospitals in UK and will continue: Brexit or not

We are pleased to be able to announce that Eumedica has partnered with a local supplier in the United Kingdom to store and ship medicines to UK Hospitals.  Please note that Eumedica will continue to take orders and issue the invoices from Manage in Belgium, while the UK market medicines will be delivered directly from our UK storage facility.

How will this benefit to our customers?

This new storage facility will ensure that we are able to respond quickly, and in a more flexible way, to any of our customers’ requests in United Kingdom. They will benefit from:

• • a faster delivery: your goods will be delivered after 24h instead of 48h
• • no border control delays
• • serialized products will be directly available in UK
• • a smooth Brexit with business continuity – whatever the final outcome

Contact us for more information

Today we are celebrating the International Day of Women and Girls in Science. This annual international day has been established to recognize the critical role women and girls play in science and technology. It is an opportunity to promote full and equal access to and participation in science for women and girls.

On this occasion we would like you to meet Fabienne Rosbrouck, our Medical Expert at Eumedica.

Contribute to scientific breakthroughs

Always interested by the wonderful world of sciences, she has sought to make a difference through her studies and professional experience. “The field of science has been attractive to me from the beginning. This is the main reason why I started my Applied Medical Biology studies with a focus on clinical research at the Université Libre de Bruxelles. I wanted to work in the medical field and research specifically because I was fascinated and I hoped to make a difference and contribute to scientific breakthroughs.”

One of Fabienne’s projects during her studies was notably to complete her thesis on immunology and the HLA system. She aimed to better understand the complexity of the immune system in order to help in the development of cures . During her studies, she has had Prof. Dr. Lise Thiry as teacher, which was an inspiration for her. “She was an incredibly active, clever and caring woman who was then deeply involved in the fight against AIDS. She got deeply involved in this research area because she also understood the discrimination involved for those suffering from this disease and the major burden of this disease in the mid-80. She also had the gift of transmitting her passion for research and science and to make it affordable to everybody.”

When sharing experience is a key

Once her studies finished, Fabienne felt like she could act at another level too. “I had this scientific background and knowledge but I wanted to discover some other horizons too. Therefore I started to look at the pharmaceutical industry. I have then accomplished a second Master in Economic and Commercial sciences at the Ichec in Brussels. My goal was to enter in a Sales & marketing team to combine the scientific and commercial aspects. I have thus started as Medical Representative to understand who is the public out there, what are their expectations. This experience has deeply helped me in the next steps of my career.”

Later, Fabienne experienced different roles such as Product Manager, Training Manager and Medical Information/Affairs Manager. “Through these experiences, I had the opportunity to interact with several stakeholders (internal and external) but also to keep deepening my scientific knowledge in several therapeutic areas. It’s very challenging because you’re in a continuous learning process. You also work with different types of stakeholders, meaning that it requires to constantly understand and anticipate their needs in order to respond and act appropriately, while respecting the rigorous scientific context.”

Eumedica, the right fit

Since September, Fabienne has strengthened the Medical Affairs Team as Medical Expert at Eumedica. “I started to work for Eumedica because of the scientific challenge it represents. Indeed, the molecules we notably promote are really niche and of high added-value to the medical doctors and the patients. And it’s very exciting to explain them to our delegates and to discuss them with various high level specialists.

Moreover, since I’ve started, I feel a lot of conviviality and qualitative human relationships. And as we speak about the place of women in the world, Eumedica is a workplace where everyone stands on equal terms, women and men. I believe that organizing a specific day to honor women and girls in the scientific world is a good step and contributes to improve the day-to-day of women at their workplace too. But let’s not stop to that one day and let’s think about this every day.“

Eumedica is delighted to announce the appointment of Virginie De Coster as new Managing Director. Virginie has joined Eumedica in 2017 and worked as Chief Financial Officer – Head of Administration/Finance. Previously, she notably held the role of Financial Director at GSK Pharmaceuticals.

With more than 10 years’ experience in the pharmaceutical industry, she will bring her expertise and intend to share her extensive knowledge with the whole team.

“Managing a SME is finding the right and exciting balance between the strategic vision and the operational management. I’m looking forward to further developing Eumedica and continuing to deliver high-quality tailored services to our clients. ” Virginie De Coster